Pavmed Inc (PAVM) - Product Pipeline Analysis, 2018 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Pavmed Inc Company Overview 4
Pavmed Inc Company Snapshot 4
Pavmed Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Pavmed Inc – Pipeline Analysis Overview 7
Pavmed Inc - Key Facts 7
Pavmed Inc - Major Products and Services 8
Pavmed Inc Pipeline Products by Development Stage 9
Pavmed Inc Pipeline Products Overview 11
Caldus - Renal Denervation 11
Caldus - Renal Denervation Product Overview 11
Caldus - Traditional Tissue Ablation 12
Caldus - Traditional Tissue Ablation Product Overview 12
CarpX 13
CarpX Product Overview 13
DisappEAR 14
DisappEAR Product Overview 14
NextCath 15
NextCath Product Overview 15
NextFlo 16
NextFlo Product Overview 16
PortIO 17
PortIO Product Overview 17
PortIO Device - Next Generation 18
PortIO Device - Next Generation Product Overview 18
Pavmed Inc - Key Competitors 19
Pavmed Inc - Key Employees 20
Pavmed Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Pavmed Inc, Recent Developments 22
Jul 11, 2018: PAVmed Appoints Shaun O’Neil Chief Commercial Officer 22
Jul 09, 2018: Nasdaq Notifies PAVmed of Regained Compliance with Continued Listing Requirements 22
Jun 27, 2018: PAVmed Provides Business Update 23
May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 24
Dec 18, 2017: Fierce Innovation Awards 2017 Recognizes PAVmeds CarpX Device for Technology Innovation 25
Nov 28, 2017: Pavmed Files 510(K) Submission With FDA for Carpx Device to Treat Carpal Tunnel Syndrome 26
Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 27
Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 28
May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 29
May 10, 2017: PAVmed to Hold Business Update Conference Call on May 17th 30
Appendix 31
Methodology 31
About GlobalData 34
Contact Us 34
Disclaimer 34
Summary
Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed’s product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company has operations throughout the US. Pavmed is headquartered in New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Pavmed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company